1 LUMAXTECH share price target reports by brokerages below. See what is analyst's view on LUMAXTECH share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
Given its diversified product portfolio, debt-free balance sheet, a consistent dividend pay-out record (+20%), and efficient working capital cycle (20 days), we maintain our positive view on the stock. We cut our EPS by 14/12% for FY20/21E EPS factoring in current slowdown in 2W space. At CMP stock is trading at 12/10x for FY20/21E which looks compelling, we maintain Buy, with a lower target price of Rs 130(based on 15xFY21E EPS).
Given its healthy balance sheet, consistent dividend payout (+20%), and efficient working capital cycle (15 days), we maintain our positive view on the stock. We have reduced EPS estimates by 17% over FY19-21E to factor in the impact due to the SMT business. We Maintain BUY with a revised TP of Rs 180 at 16x FY21E EPS.
Valuation: Given its debt free balance sheet, a consistent dividend payout record (+20%), mid teens ROE/ROCE (~15%) and efficient working capital cycle (15 days), we maintain our positive view on the stock. We have reduced EPS estimates by 5% over FY19-21E to factor in the moderation in 2W demand and are lowering our target PE Multiple to 16x. We Maintain BUY with a revised TP of Rs 208 (16xDec-18).
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.